|
| 36063397 | Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022). | Clin Infect Dis | 2024 |
| 38009954 | COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trial. | Microbiol Spectr | 2024 |
| 38095433 | Erratum for Gebo et al., "Early antibody treatment, inflammation, and risk of post-COVID conditions". | mBio | 2024 |
| 36268708 | Absence of pathogenic viruses in COVID-19 convalescent plasma. | Transfusion | 2023 |
| 37859995 | Rates Among Hospitalized Patients With COVID-19 Treated With Convalescent Plasma: A Systematic Review and Meta-Analysis. | Mayo Clin Proc Innov Qual Outcomes | 2023 |
| 37659419 | Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study. | Lancet Microbe | 2023 |
| 37534607 | Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trials. | Transfusion | 2023 |
| 38088978 | Teaching Everyone Everywhere All at Once: Leveraging Social Media to Implement a Multisite Fungal Diagnostics Curriculum. | Open Forum Infect Dis | 2023 |
| 37724870 | Early antibody treatment, inflammation, and risk of post-COVID conditions. | mBio | 2023 |
| 35579509 | Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial. | Clin Infect Dis | 2023 |
| 36987595 | Coronavirus Disease 2019 Convalescent Plasma Utilization in the United States: Data From the National Inpatient Sample. | Clin Infect Dis | 2023 |
| 37070102 | Vaccines and therapeutics for immunocompromised patients with COVID-19. | EClinicalMedicine | 2023 |
| 37131659 | Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial. | medRxiv | 2023 |
| 37129285 | Convalescent plasma therapy in COVID-19: Unravelling the data using the principles of antibody therapy. | Expert Rev Respir Med | 2023 |
| 36925381 | Invasive fungal infections after respiratory viral infections in lung transplant recipients are associated with lung allograft failure and chronic lung allograft dysfunction within 1 year. | J Heart Lung Transplant | 2023 |
| 36809542 | Coronavirus Disease 2019 Convalescent Plasma Reaches the Slope of Enlightenment in the Gartner Hype Cycle. | Clin Infect Dis | 2023 |
| 36740590 | Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019. | Clin Infect Dis | 2023 |
| 36603694 | Nirmatrelvir and COVID-19: development, pharmacokinetics, clinical efficacy, resistance, relapse, and pharmacoeconomics. | Int J Antimicrob Agents | 2023 |
| 36824860 | Early Treatment, Inflammation and Post-COVID Conditions. | medRxiv | 2023 |
| 36329567 | Discriminating endogenous vaccine-elicited anti-Spike antibody responses from exogenous anti-Spike monoclonal antibodies: The case of Evusheld. | J Med Virol | 2023 |
| 34668008 | Lessons Learned from Coronavirus Disease 2019 (COVID-19) Therapies: Critical Perspectives From the Infectious Diseases Society of America (IDSA) COVID-19 Treatment Guideline Panel. | Clin Infect Dis | 2022 |
| 35353960 | Early Outpatient Treatment for Covid-19 with Convalescent Plasma. | N Engl J Med | 2022 |
| 35352362 | How do I implement an outpatient program for the administration of convalescent plasma for COVID-19? | Transfusion | 2022 |
| 35443020 | Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern. | Blood Adv | 2022 |
| 35854988 | Bloodstream Infections in Hematologic Malignancy Patients With Fever and Neutropenia: Are Empirical Antibiotic Therapies in the United States Still Effective? | Open Forum Infect Dis | 2022 |
| 36530631 | Treatment recommendations for non-HIV associated cryptococcal meningoencephalitis including management of post-infectious inflammatory response syndrome. | Front Neurol | 2022 |
| 36314809 | The Potential Role of Passive Antibody-Based Therapies as Treatments for Monkeypox. | mBio | 2022 |
| 36344141 | Limitations on PassItOn Design and Execution Should Temper Negative Conclusions. | Chest | 2022 |
| 34855624 | Pharmacokinetics of high-titer anti-SARS-CoV-2 human convalescent plasma in high-risk children. | JCI Insight | 2022 |
| 35172720 | Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2. | BMC Immunol | 2022 |
| 35135758 | WHO covid-19 drugs guideline: reconsider using convalescent plasma. | BMJ | 2022 |
| 34927038 | The silent and dangerous inequity around access to COVID-19 testing: A call to action. | EClinicalMedicine | 2022 |
| 35104245 | Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection. | JCI Insight | 2022 |
| 34668010 | Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-edged Swords. | Clin Infect Dis | 2022 |
| 32949093 | Quantifying infection risks in incompatible living donor kidney transplant recipients. | Am J Transplant | 2021 |
| 33718854 | Correcting COVID-19 vaccine misinformation: Lancet Commission on COVID-19 Vaccines and Therapeutics Task Force Members. | EClinicalMedicine | 2021 |
| 33493365 | ABO blood group and SARS-CoV-2 antibody response in a convalescent donor population. | Vox Sang | 2021 |
| 33879585 | Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma. | mBio | 2021 |
| 33571169 | Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality. | J Clin Invest | 2021 |
| 33709127 | EORTC/MSGERC Definitions of Invasive Fungal Diseases: Summary of Activities of the Intensive Care Unit Working Group. | Clin Infect Dis | 2021 |
| 33532806 | Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers. | medRxiv | 2021 |
| 34981068 | Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma. | medRxiv | 2021 |
| 34966840 | Outcomes of SOT Recipients With COVID-19 in Different Eras of COVID-19 Therapeutics. | Transplant Direct | 2021 |
| 34931202 | Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection. | medRxiv | 2021 |
| 34793394 | Influenza-Associated Pulmonary Aspergillosis: Seek, and You Shall Find! | Crit Care Med | 2021 |
| 34401890 | Antibody Attributes that Predict the Neutralization and Effector Function of Polyclonal Responses to SARS-CoV-2. | medRxiv | 2021 |
| 34695724 | Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers. | J Clin Virol | 2021 |
| 34516558 | Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed. | PLoS Med | 2021 |
| 34099998 | Beyond the jab: A need for global coordination of pharmacovigilance for COVID-19 vaccine deployment. | EClinicalMedicine | 2021 |
| 34036254 | Urgent needs to accelerate the race for COVID-19 therapeutics. | EClinicalMedicine | 2021 |